Management of locally advanced cervical cancer in pregnancy: A case report

Emanuela Rabaiotti, Cristina Sigismondi, Serena Montoli, Giorgia Mangili, Massimo Candiani, Riccardo Viganò

Research output: Contribution to journalArticlepeer-review


Background. Carcinoma of the cervix is the most common malignancy associated with pregnancy. In the first and second trimesters patients should receive the same treatment as is used in nonpregnant women and termination is advised. In selected cases neoadjuvant chemotherapy (NACT) could be proposed but only a few cases have been reported. Case. A 27-year-old woman, gravida 1 para 0, at 15 weeks' gestation, was diagnosed with FIGO stage IB2 squamous cervical cancer. After refusing to terminate pregnancy, she was treated with neoadjuvant chemotherapy (cisplatin) starting at 18 weeks. A cesarean section with radical surgery was performed at 32 weeks and a healthy baby delivered. Four weeks later the patient started chemoradiation therapy. She relapsed 1 year after surgery and died when her child was 2 years old. Conclusion. NACT followed by radical surgery was an unsuccessful treatment in our patient; platinum-based chemotherapy was harmless to the child up to the last follow-up.

Original languageEnglish
Pages (from-to)623-626
Number of pages4
Issue number4
Publication statusPublished - 2010


  • Cervical carcinoma
  • Cisplatin
  • Neoadjuvant chemotherapy
  • Pregnancy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)


Dive into the research topics of 'Management of locally advanced cervical cancer in pregnancy: A case report'. Together they form a unique fingerprint.

Cite this